Dr. Lam’s research is in early detection and chemoprevention of lung cancer. The research focus of the group is to develop a comprehensive lung cancer control strategy integrating smoking cessation, risk assessment, early detection, chemoprevention, diagnosis, treatment and surveillance. Dr. Stephen Lam is the Principal Investigator of the Pan-Canadian Early Detection of Lung Cancer Study involving eight centers across Canada from coast to coast. The team has developed a web-based lung cancer risk prediction tool to identify smokers at sufficient risk for screening with low dose Computed Tomography and to evaluate the incremental value of biomarkers as well as development of a highly accurate lung nodule malignancy risk calculator. Dr. Lam also chairs the Canadian Partnership Against Cancer Expert Panel on Lung Cancer Screening and has published an on line document entitled, “Summary of Existing and New Evidence on Lung Cancer Screening”, to guide physicians and health care policy makers to make an informed decision on screening. The current focus of his group is to translate lung cancer screening from applied research to clinical practice to impact the outcome of patients with lung cancer – the most common cause of cancer deaths in the world.
Stephen Lam Lab
Dr. Stephen Lam, MD, FRCPC
Mary Anne Dy Buncio
Human Observer vs Prediction Model for Lung Nodule Malignancy Risk Estimation.
Lung Cancer Screening in Never-Smokers.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort.
BMJ open, 2019
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.